FDA puts Neose anemia trial on hold

The FDA has put Neose Technologies' planned clinical trial of its experimental anemia drug on hold as it seeks more information.The Horsham, Pennsylvania-based biotech filed an IND application for NE-180 in June. Neose had hoped to begin a Phase I trial in the third quarter, but said an FDA delay would likely shove that start date back by a quarter.

- read this story from the Philadelphia Business Journal for more